Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1

SC Yang, SH Chang, PW Hsieh, YT Huang… - Free Radical Biology …, 2017 - Elsevier
Abstract Formyl peptide receptor 1 (FPR1) is an emerging therapeutic target for the
discovery of drugs to treat neutrophilic inflammatory diseases. However, development of …
被引用次数：30 相关文章

Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1

SC Yang, SH Chang, PW Hsieh, YT Huang… - Free Radical Biology …, 2017 - infona.pl
Formyl peptide receptor 1 (FPR1) is an emerging therapeutic target for the discovery of
drugs to treat neutrophilic inflammatory diseases. However, development of FPR1 …

Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1.

SC Yang, SH Chang, PW Hsieh, YT Huang… - Free Radical Biology …, 2017 - europepmc.org
Formyl peptide receptor 1 (FPR1) is an emerging therapeutic target for the discovery of
drugs to treat neutrophilic inflammatory diseases. However, development of FPR1 …

Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1

SC Yang, SH Chang, PW Hsieh… - … radical biology & …, 2017 - pubmed.ncbi.nlm.nih.gov
Formyl peptide receptor 1 (FPR1) is an emerging therapeutic target for the discovery of
drugs to treat neutrophilic inflammatory diseases. However, development of FPR1 …

Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1

TL Hwang - 2017 - Eur Respiratory Soc
Formyl peptide receptor 1 (FPR1) is an emerging therapeutic target for the discovery of
drugs to treat neutrophilic inflammatory diseases. However, development of FPR1 …